Rockefeller Financial to sell 200,000 Roivant shares (ROIV)

Rhea-AI Filing Summary

Rockefeller Financial LLC filed a Form 144 notice to sell 200,000 Common Shares of Roivant Sciences Ltd. The sale is described as resulting from an options exercise with grant date 04/20/2022 and the proposed transaction date 03/17/2026, with proceeds to be transmitted by wire.

The excerpt also lists recent sales by Eric Venker, including multiple transactions of 200,000 shares on 02/13/2026 and 01/12/2026 and smaller tranches on other dates; these prior sales are shown with corresponding gross amounts in the table.

Insights

Securities Counsel

Routine licensed affiliate resale notice under Rule 144; not a company issuance.

This filing notifies the market that an affiliate intends to sell 200,000 Common Shares via an options exercise on 03/17/2026. The filing lists the grant date 04/20/2022 and identifies the distribution method as wire.

Prior sale lines for Eric Venker shown in the excerpt document recent dispositions, with specific trade dates and gross proceeds. Cash‑flow treatment and issuer proceeds are not asserted in the provided excerpt.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Rockefeller Financial LLC 45 Rockefeller Plaza Floor 5 New York NY 10111	200000	5648836.44	715701137	03/17/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Shares	03/17/2026	Options Exercise - Grant Date 04/20/2022	Roivant Sciences Ltd.			200000	03/17/2026	Wire

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Eric Venker c/o Roivant Sciences LTD 7th Floor, 50 Broadway, London X0 SW1H0DB	Common Shares	02/20/2026	7051	191434.65
Eric Venker c/o Roivant Sciences LTD 7th Floor, 50 Broadway London X0 SW1H0DB	Common Shares	02/13/2026	200000	5298373.26
Eric Venker c/o Roivant Sciences LTD 7th Floor, 50 Broadway London X0 SW1H0DB	Common Shares	01/12/2026	200000	4383694.07
Eric Venker c/o Roivant Sciences LTD 7th Floor, 50 Broadway London X0 SW1H0DB	Common	12/24/2025	75000	1689750.00
Eric Venker c/o Roivant Sciences LTD 7th Floor, 50 Broadway London X0 SW1H0DB	Common	12/23/2025	200000	4490540.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the ROIV Form 144 filed by Rockefeller Financial LLC state?

The filing states Rockefeller Financial LLC intends to sell 200,000 Common Shares of Roivant Sciences Ltd via an options exercise dated 04/20/2022, with proposed sale date 03/17/2026 and distribution method listed as wire.

Who else is shown selling ROIV shares in the excerpt?

The excerpt lists multiple prior sales by Eric Venker, including 200,000 share transactions on 02/13/2026 and 01/12/2026, with gross amounts reported alongside each sale in the table.

Does this Form 144 indicate proceeds go to the company (ROIV)?

The excerpt does not state that proceeds go to the issuer. The filing describes an affiliate resale from an options exercise and lists wire as the distribution method; it does not assert issuer receipt of proceeds in the provided text.

What is the transaction trigger described in the Form 144 excerpt?

The sale is described as resulting from an Options Exercise with grant date 04/20/2022. The proposed sale date is listed as 03/17/2026, consistent with an affiliated holder converting derivatives and offering shares for resale.

Are the specific gross proceeds for prior sales shown in the filing excerpt?

Yes; the excerpt lists gross amounts for prior sales, for example 200,000 shares on 02/13/2026 with $5,298,373.26 and 200,000 shares on 01/12/2026 with $4,383,694.07 as shown in the table.